Li, S.; Liu, W.; Zheng, J.; Ren, L.; Zhou, C.; Wu, Q.; Ai, Z.
PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential. Molecules 2026, 31, 1811.
https://doi.org/10.3390/molecules31111811
AMA Style
Li S, Liu W, Zheng J, Ren L, Zhou C, Wu Q, Ai Z.
PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential. Molecules. 2026; 31(11):1811.
https://doi.org/10.3390/molecules31111811
Chicago/Turabian Style
Li, Shenshen, Wei Liu, Jiaojiao Zheng, Lingyu Ren, Changhao Zhou, Qiao Wu, and Zhilong Ai.
2026. "PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential" Molecules 31, no. 11: 1811.
https://doi.org/10.3390/molecules31111811
APA Style
Li, S., Liu, W., Zheng, J., Ren, L., Zhou, C., Wu, Q., & Ai, Z.
(2026). PKM2-Mediated Glycolytic Reprogramming in Thyroid Cancer: Mechanistic Insights and Therapeutic Potential. Molecules, 31(11), 1811.
https://doi.org/10.3390/molecules31111811